Virtu Financial’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42K Sell
14,903
-38,648
-72% -$118K ﹤0.01% 1312
2025
Q4
$223K Buy
53,551
+14,583
+37% +$76.8K 0.01% 974
2025
Q3
$165K Buy
+38,968
New +$147K 0.01% 952
2024
Q3
Sell
-11,233
Closed -$25K 1544
2024
Q2
$25K Buy
+11,233
New +$34.1K ﹤0.01% 1003
2023
Q1
Sell
-39,169
Closed -$44K 1706
2022
Q4
$44K Buy
39,169
+26,345
+205% +$35.1K 0.01% 1107
2022
Q3
$21K Buy
+12,824
New +$24K ﹤0.01% 1385
2022
Q2
Sell
-16,261
Closed -$26K 1754
2022
Q1
$26K Sell
16,261
-1,402
-8% -$2.71K ﹤0.01% 1260
2021
Q4
$37K Buy
+17,663
New +$50.4K ﹤0.01% 1408
2021
Q2
Sell
-14,683
Closed -$32K 1698
2021
Q1
$32K Buy
+14,683
New +$32.9K ﹤0.01% 1476
2019
Q4
$157K Buy
+54,738
New +$190K 0.02% 993
2018
Q4
Sell
-17,752
Closed -$107K 1699
2018
Q3
$107K Buy
+17,752
New +$97.7K 0.01% 1181

Other funds holding GALT